Alvaro Arjona
@alarjosan
Oncologic, pancreatic and transplant surgeon. PMP researcher. European board surgical oncology. Coordinator of GECOP. Runner.
ID: 717347996359372800
https://www.researchgate.net/profile/Alvaro_Arjona-Sanchez 05-04-2016 13:47:44
5,5K Tweet
3,3K Followers
2,2K Following
Alvaro Arjona realiza la primera #PIPAC en Hospital Cruz Roja de Córdoba, siendo la 1° vez en un hospital privado de #CordobaEsp Un tratamiento que ofrecemos a pacientes con cáncer con diseminación abdominal. ¡Enhorabuena a todo el equipo que lo ha hecho posible! 🙌🏻
RAND Spa is happy to attend the "Comprehensive Management of Peritoneal Surface Malignancy Workshop and PIPAC Course", taking place at the National Cancer Centre Singapore on April 14-16, under the direction of Prof. Claramae Chia , and endorsed by Peritoneal Surface Oncology Group International #HIPEC
Official workshops and course photo of Singapore PSM HIPEC and PIPAC meet ISSPP Peritoneal Surface Oncology Group International Indian society of peritoneal surface malignancy Claramae Chia
The annual "Comprehensive Management of Peritoneal Surface Malignancy Workshop and PIPAC Course" at the National Cancer Centre Singapore has just finished and it was a success! Thank you Claramae Chia for the amazing organization and see you all next year! Peritoneal Surface Oncology Group International ISSPP #HIPEC
This is incredible news, and hopefully will clarify the decision-making algorithm for high-risk non metastatic CRC. We look forward to hearing more. Buena suerte Alvaro Arjona.
First evidence for dysregulation of the genes of pivotal RNAregulatory in PMP, implying that these targetable mech may be functionally altered. IMIBIC Hospital Universitario Reina Sofía Grupo Español de Tratamiento de Tumores Digestivos News (PMP) Pseudomyxoma Peritonei Appendix Cancer Appendix Cancer PMP Research Foundation Peritoneal Surface Oncology Group International ISSPP AMARAPE Asociación Peritoneum rdcu.be/ejS4C
#PSOGI2025 #PSOGIBARCELONA The 15th International congress on peritoneal malignancies is approaching Paul H Sugarbaker invites all peritoneal malignancy experts and enthusiasts from around the 🌎 🌏 🌍 to participate and contribute to the largest meeting on peritoneal malignancies
"Adjuvant HIPEC significantly reduced the locoregional recurrence rate in right-sided locally advanced colon cancer, but not in the overall study population." pedro villarejo campos
¡Enhorabuena a nuestro compañero en el Comité Científico de la aecirujanos, Álvaro Arjona por su brillante publicación en BJS acerca del valor de la HIPEC en cáncer colorrectal con metástasis peritoneales! Alvaro Arjona Pedro Cascales #HIPEC BJS Academy
Este viernes 23 celebramos la V mesa investigación en PMP , adjunto programa con link gratuito Damian Garcia-Olmo, Professor of Surgery Asociación Peritoneum SEOQ | Los cirujanos del cáncer #operarelcancer aecirujanos Asociación Española Contra el Cáncer FundacionJiménezDíaz IMIBIC Grupo Español de Tratamiento de Tumores Digestivos News (PMP) Pseudomyxoma Peritonei Appendix Cancer Appendix Cancer PMP Research Foundation
Alvaro Arjona Damian Garcia-Olmo, Professor of Surgery Asociación Peritoneum SEOQ | Los cirujanos del cáncer #operarelcancer aecirujanos Asociación Española Contra el Cáncer FundacionJiménezDíaz IMIBIC Grupo Español de Tratamiento de Tumores Digestivos News (PMP) Pseudomyxoma Peritonei Appendix Cancer Appendix Cancer PMP Research Foundation Enhorabuena por mantener esta convocatoria anual y aportar nuevo conocimiento en esta enfermedad rara
Paclitaxel-based HIPEC showed better outcomes than cisplatin, particularly for patients with a PCI of 15 or lower on this multicenter study, debate is open for Paclita as alternative to Cis Pedro Cascales SEOQ | Los cirujanos del cáncer #operarelcancer ESGO Peritoneal Surface Oncology Group International INDEPSO link.springer.com/article/10.124…
🎓 V Mesa Redonda de Investigación en Pseudomixoma peritoneal 📍 Fundación Jiménez Díaz – Sala de Juntas (5ª planta) 📅 Vie 23 mayo 2025 | 🕚 11:00–13:15 🎥 Presencial y online (Teams) (link en comentarios) Con expertos en oncología de precisión, biología molecular y nuevas terapias
Did you know that CRS and laparoscopic #HIPEC is an easy and safe treatment in selected patients with #peritoneal malignancies? Did you know that Dr. Arjona Sanchez Alvaro Arjona from Hospital Universitario Reina Sofía is one of the most experienced surgeons in this technique?
V mesa investigación en Pseudomyxoma peritoneo en FundacionJiménezDíaz , compartiendo conocimiento en esta rara enfermedad Damian Garcia-Olmo, Professor of Surgery Grupo Español de Tratamiento de Tumores Digestivos Hospital Universitario Reina Sofía IMIBIC
